Is Grace Risk Score the Holy Grail in Risk Stratification or Can We Improve it Even Further with Additional Biomarkers?

Timóteo, AT2021-07-162021-07-162020Arq Bras Cardiol. 2020 Apr;114(4):673-674.http://hdl.handle.net/10400.17/3777engBiomarkersHumansNatriuretic Peptide, BrainPeptide FragmentsPrognosisRisk AssessmentAcute Coronary SyndromeHSM CARIs Grace Risk Score the Holy Grail in Risk Stratification or Can We Improve it Even Further with Additional Biomarkers?other10.36660/abc.20200171